Beta Cell Differentiation Protocol for Glucose Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protocols for differentiating human pluripotent stem cells into functional mature beta cells that respond to glucose stimulation in vitro are inefficient, resulting in cells that are functionally immature and co-express other hormones, limiting their effectiveness in treating type 1 diabetes.
Innovation Solution
A novel two-step method involving small-molecule screens to induce INS+ and NKX6.1+ double-positive cells, followed by a protocol that generates glucose-responsive insulin-secreting beta cells capable of repeated glucose challenges in dynamic perfusion assays, with gamma-Aminobutyric acid (GABA) administration potentially enhancing the functional effect post-transplantation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current differentiation protocols are used to generate insulin-producing cells from hPSCs, then insulin production is achieved, but the cells co-express other hormones and fail to respond properly to glucose stimulation
Solution Approach 1:
The differentiation protocol is divided into distinct sequential stages: definitive endoderm formation, pancreatic endoderm differentiation, endocrine progenitor specification, and mature beta cell maturation. Each stage uses specific small molecule compounds to guide cells through precise developmental transitions, ensuring functional maturity while avoiding hormone co-expression
Solution Approach 2:
The protocol systematically changes chemical parameters by introducing specific small molecule compounds at defined time points during differentiation. These parameter changes include modulation of signaling pathways through compounds that mimic or block specific growth factors, thereby controlling cell fate decisions and ensuring proper beta cell functional maturation
2Measurement precision
If static incubation studies are used to assess beta cell function, then some glucose responsiveness is observed, but dynamic perfusion assays reveal functionally immature characteristics
Solution Approach 1:
The differentiation protocol incorporates preliminary maturation steps that prepare beta cells for functional assessment before transplantation or experimentation. Cells are pre-differentiated through controlled stages that establish glucose-responsive insulin secretion capacity in advance, reducing the time needed for functional maturation after generation
3Quantity of substance
If organ donation is used for islet transplantation, then functional beta cells are provided, but the supply is limited by donor availability
Solution Approach 1:
Human pluripotent stem cells possess self-renewal capacity that allows indefinite proliferation in culture. This self-service property enables continuous production of differentiated beta cells without requiring additional donor organs, effectively scaling cell availability while maintaining functional quality through controlled differentiation protocols
Data Source
Figure 1
Figure 2A~2B
Figure 3A~3C
AI summary
The present invention relates to generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors. The present invention also relates to functional beta cells produced by said methods and uses of said beta cells.